open access

Vol 52, No 6 (2021)
Original research article
Submitted: 2021-02-22
Accepted: 2021-03-30
Published online: 2021-05-10
Get Citation

Comparison of various diagnostic methods in assessing platelet count in patients with immune thrombocytopenia

Michał Witkowski1, Magdalena Witkowska2, Marzena Tybura-Sawicka3, Agata Majchrzak1, Tadeusz Robak4, Piotr Smolewski2
DOI: 10.5603/AHP.a2021.0030
·
Acta Haematol Pol 2021;52(6):584-589.
Affiliations
  1. Department of Haematology, Copernicus Memorial Hospital, Lodz, Poland, Pabianicka 62, 93-513 Lodz, Poland
  2. Department of Experimental Haematology, Medical University of Lodz, Poland, Lodz, Poland
  3. Department of Haemostasis Disorders, Medical University of Lodz, Poland, Lodz, Poland
  4. Hematology Clinic, Medical University of Lodz, Poland, Lodz, Poland

open access

Vol 52, No 6 (2021)
ORIGINAL RESEARCH ARTICLE
Submitted: 2021-02-22
Accepted: 2021-03-30
Published online: 2021-05-10

Abstract

Introduction: Accurate platelet count (PLTC) in immune thrombocytopenia is important in order to make therapeutic decisions. The basic method of assessing PLTC is peripheral blood morphology with EDTA or with citrate. The older way of assessing PLTC is measurement under the microscope (FONIO), and the newer way is the fluorescent method. The purpose of this study was to compare PLTC methods, and find the most reliable. Material and methods: PLTC was assessed using five methods in adult patients with previously untreated ITP (EDTA, citrate, FONIO, fluorescent, and immunofluorescent methods). Results: 66 patients were enrolled in the study. The median age was 56 and 56% were men. Median PLTC in EDTA was 69 G/L, in citrate 69 G/L, in fluorescence 69 G/L, in FONIO 90 G/L, and in immunofluorescence 83 G/L. A significant difference in PLTC was observed in comparing EDTA to immunofluorescence (53% ±123%), followed by FONIO (51% ±91%). PLTC from immunofluorescence differed from the fluorescent method by 40% ±78%. Conclusions: The most valuable method for obtaining PLTC is the immunofluorescent method. These findings are especially important in helping to make therapeutic decisions during a challenging time for accessing medical care like a pandemic.

Abstract

Introduction: Accurate platelet count (PLTC) in immune thrombocytopenia is important in order to make therapeutic decisions. The basic method of assessing PLTC is peripheral blood morphology with EDTA or with citrate. The older way of assessing PLTC is measurement under the microscope (FONIO), and the newer way is the fluorescent method. The purpose of this study was to compare PLTC methods, and find the most reliable. Material and methods: PLTC was assessed using five methods in adult patients with previously untreated ITP (EDTA, citrate, FONIO, fluorescent, and immunofluorescent methods). Results: 66 patients were enrolled in the study. The median age was 56 and 56% were men. Median PLTC in EDTA was 69 G/L, in citrate 69 G/L, in fluorescence 69 G/L, in FONIO 90 G/L, and in immunofluorescence 83 G/L. A significant difference in PLTC was observed in comparing EDTA to immunofluorescence (53% ±123%), followed by FONIO (51% ±91%). PLTC from immunofluorescence differed from the fluorescent method by 40% ±78%. Conclusions: The most valuable method for obtaining PLTC is the immunofluorescent method. These findings are especially important in helping to make therapeutic decisions during a challenging time for accessing medical care like a pandemic.

Get Citation

Keywords

flow cytometry, immunofluorescence, immune thrombocytopenia, platelet count

Supp./Additional Files (1)
cover letter
Download
13KB
About this article
Title

Comparison of various diagnostic methods in assessing platelet count in patients with immune thrombocytopenia

Journal

Acta Haematologica Polonica

Issue

Vol 52, No 6 (2021)

Article type

Original research article

Pages

584-589

Published online

2021-05-10

Page views

4197

Article views/downloads

351

DOI

10.5603/AHP.a2021.0030

Bibliographic record

Acta Haematol Pol 2021;52(6):584-589.

Keywords

flow cytometry
immunofluorescence
immune thrombocytopenia
platelet count

Authors

Michał Witkowski
Magdalena Witkowska
Marzena Tybura-Sawicka
Agata Majchrzak
Tadeusz Robak
Piotr Smolewski

References (27)
  1. Cines DB, Bussel JB, Liebman HA, et al. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009; 113(26): 6511–6521.
  2. Witkowski M, Witkowska M, Robak T. Autoimmune thrombocytopenia: current treatment options in adults with a focus on novel drugs. Eur J Haematol. 2019; 103(6): 531–541.
  3. Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019; 3(23): 3829–3866.
  4. Liu J, Zheng X, Tong Q, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020; 92(5): 491–494.
  5. Nishioka T, Yamane T, Takubo T, et al. Detection of various platelet-associated immunoglobulins by flow cytometry in idiopathic thrombocytopenic purpura. Cytometry B Clin Cytom. 2005; 68(1): 37–42.
  6. Fonio A. Über ein neues Verfahren der Blutplättchenzählung. Dtsch Z Chir. 1912; 117(1–2): 176–194.
  7. International Council for Standardization in Haematology Expert Panel on Cytometry International Society of Laboratory Hematology Task Force on Platelet Counting. Platelet Counting by the RBC/Platelet Ratio Method. Am J Clin Pathol. 2001; 115(3): 460–464.
  8. Gatt A, Bonello F, Buttigieg R, et al. Flow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies. Blood Transfus. 2014; 12(4): 479–484.
  9. Schrezenmeier H, Müller H, Gunsilius E, et al. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis. Thromb Haemost. 1995; 73(3): 506–513.
  10. Lippi G, Plebani M. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med. 2012; 50(8): 1281–1285.
  11. von dem Borne AE, van der Lelie H, Vos JJ, et al. Antibodies against cryptantigens of platelets. Characterization and significance for the serologist. Curr Stud Hematol Blood Transfus. 1986; 52: 33–46.
  12. Bowles KM, Bloxham DM, Perry DJ, et al. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura. Br J Haematol. 2006; 134(3): 320–322.
  13. Harrison P, Horton A, Grant D, et al. Immunoplatelet counting: a proposed new reference procedure. Br J Haematol. 2000; 108(2): 228–235.
  14. Hoffmann JJ. Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med. 2014; 52(8): 1107–1117.
  15. Pedersen OH, Larsen ML, Grove EL, et al. Platelet characteristics in patients with essential thrombocytosis. Cytometry B Clin Cytom. 2018; 94(6): 918–927.
  16. Tanaka Y, Tanaka Y, Gondo K, et al. Performance evaluation of platelet counting by novel fluorescent dye staining in the XN-series automated hematology analyzers. J Clin Lab Anal. 2014; 28(5): 341–348.
  17. Sun Yi, Hu Z, Huang Z, et al. Compare the accuracy and precision of Coulter LH780, Mindray BC-6000 Plus, and Sysmex XN-9000 with the international reference flow cytometric method in platelet counting. PLoS One. 2019; 14(5): e0217298.
  18. Dickerhof R, von Ruecker A. Enumeration of platelets by multiparameter flow cytometry using platelet-specific antibodiesand fluorescent reference particles. Clinical & Laboratory Haematology. 1995; 17(2): 163–172.
  19. Panzer S, Rieger M, Vormittag R, et al. Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia. Eur J Clin Invest. 2007; 37(10): 814–819.
  20. van Bladel ER, Laarhoven AG, van der Heijden LB, et al. Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts. Blood. 2014; 123(10): 1556–1563.
  21. van Asten I, Schutgens REG, Baaij M, et al. Validation of flow cytometric analysis of platelet function in patients with a suspected platelet function defect. J Thromb Haemost. 2018; 16(4): 689–698.
  22. Israels SJ. Laboratory testing for platelet function disorders. Int J Lab Hematol. 2015; 37(Suppl 1): 18–24.
  23. Smith GA, Ranasinghe E, Ouwehand WH. The importance of using multiple techniques for detection of platelet antibodies. Vox Sang. 2007; 93(4): 306–308.
  24. Rosenfeld CS, Nichols G, Bodensteiner DC. Flow cytometric measurement of antiplatelet antibodies. Am J Clin Pathol. 1987; 87(4): 518–522.
  25. Romero-Guzman LT, Lopez-Karpovitch X, Paredes R, et al. Detection of platelet-associated immunoglobulins by flow cytometry for the diagnosis of immune thrombocytopenia: a prospective study and critical review. Haematologica. 2000; 85(6): 627–631.
  26. Tomer A. Autoimmune thrombocytopenia: determination of platelet-specific autoantibodies by flow cytometry. Pediatr Blood Cancer. 2006; 47(5 Suppl): 697–700.
  27. Hézard N, Simon G, Macé C, et al. Is flow cytometry accurate enough to screen platelet autoantibodies? Transfusion. 2008; 48(3): 513–518.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl